Jason Haas
Independent DirectorMr. Jason Haas, MBA, is Chief Financial Officer of Odyssey Therapeutics, Inc. from December 2024. Mr. Haas serves as an Independent Director at Ligand Pharmaceuticals Incorporated since June 2022. He was Chief Financial Officer of Syros Pharmaceuticals, Inc. from October 2021 until November 2024. Mr. Haas served as Co-Head of Americas, Healthcare Investment Banking at Barclays plc from June 2016 to October 2021 where he executed an array of strategic transactions across the public and private markets and supported companies through equity and debt financings, mergers and acquisitions, divestitures and spin-offs. Prior to joining Barclays in 2016, he served as Head of Americas, Healthcare Investment Banking at Deutsche Bank AG. Prior to his role at Deutsche Bank, he was a Managing Director on the Healthcare Investment Banking team at Goldman Sachs & Co, where he covered life sciences companies. Mr. Haas holds an M.B.A in Finance from Columbia Business School and a B.A in International Relations and Economics from Colgate University.
Positions
- Company NameLigand Pharmaceuticals IncorporatedStock CodeLGNDPositionIndependent DirectorColleagues
- TCTodd C. DavisCEO & Director
- JWJohn Warren KozarichIndependent Chairman
- OEOctavio EspinozaChief Financial Officer
- ATAndrew T. ReardonChief Legal Officer & Secretary
- PJPaul J. HaddenSenior Vice President of Investments & Business Development
- MJMelanie J. HermanExecutive Director of Investor Relations and Financial Planning & Analysis
- JMJason M. AryehIndependent Director
- SLStephen Lawrence SabbaIndependent Director
- JHJason HaasIndependent Director
- Company NameOdyssey Therapeutics, Inc.Stock CodeODTXPositionChief Financial OfficerColleagues
- GDGary D. GlickFounder, President, CEO & Director
- JMJeffrey Marc LeidenIndependent Chairman of the Board
- CTCollin ToddSenior Vice President of Strategy & Business Development
- ELEicke LatzScientific Co-Founder
- KLKim LewisScientific Co-Founder
- SCStephen C. BlacklowChairman of Scientific Advisory Board
- IFIan F. SmithIndependent Director
- VOValerie OdegardIndependent Director
